EL
Elicio Therapeutics, Inc. (ELTX)
NASDAQ·Healthcare·Biotechnology
$14.85
+6.53%
Mkt Cap $203.31M
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$17.00
Range $17.00 – $17.00
Implied Upside
+14.5%
Consensus $17.00 vs current $14.85
NASDAQ·Healthcare·Biotechnology
$14.85
+6.53%
Mkt Cap $203.31M
No recent rating data.
Price Target (3 analysts)
$17.00
Range $17.00 – $17.00
+14.5%
Consensus $17.00 vs current $14.85